🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Dina Schneider

Lentigen Technology (United States)

ORCID: 0000-0001-7130-7374

Also affiliated with Cara Therapeutics (United States)

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR”.

CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR

Blood(2022)10.1182/blood.2022015795

N/A

3.6DataRank · unranked

177 citations

Haiying Qin, Angela Su, Bonnie Yates, Pamela L. Wolters, Seth M. Steinberg +30 more

Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice

Gastroenterology(2020)10.1053/j.gastro.2020.02.011

N/A

0.765DataRank · unranked

163 citations

Nan Li, Yifan Zhang, Haiying Fu, Mingqian Feng, Dina Schneider +22 more

Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy

Communications Medicine(2022)10.1038/s43856-022-00116-5

N/A

0.616DataRank · unranked

16 citations

Anikó Szabó, Igli Arapi, Ruizhe Wu, Amanda Emmrich, Edward Hackett +11 more

Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101212

N/A

0DataRank · unranked

26 citations

Jun S. Wei, Nityashree Shivaprasad, Steven L. Highfill, Berkley E. Gryder, David Milewski +24 more